U.S. Seals Deal with AstraZeneca for 300 Million Doses of Potential Coronavirus Vaccine
A federal agency has made a deal that will lead to the eventual delivery of enough doses of an experimental coronavirus vaccine to innoculate every American adult at least once.
The Department of Health and Human Services (HHS) will provide AstraZeneca (NYSE: AZN) up to $1.2 billion to accelerate the development of ChAdOx1 nCoV-19, a gene therapy the British pharmaceutical giant licensed from Oxford University last month. Among other commitments, HHS will support a clinical trial with 30,000 participants to determine whether the vaccine candidate works as hoped.
In return, AstraZeneca has agreed to provide the U.S. with up to 300 million doses, the first of which could ship out before the end of 2020. AstraZeneca has also agreed to provide 100 million doses to people in Great Britain.
Source Fool.com
